Cipla Ltd.

NSE: CIPLA | BSE: 500087 | ISIN: INE059A01026 | Industry: Pharmaceuticals
| Mid-range Performer
1473.8500 -2.35 (-0.16%)
NSE Mar 27, 2025 12:40 PM
Volume: 404.9K
 

logo
Cipla Ltd.
28 Oct 2023
1473.85
-0.16%
buy
by BOB Capital Markets Ltd.
Target: 1360
BOB Capital Markets Ltd.
Q2 EBITDA/PAT 14%/15% ahead of consensus underpinned by strong growth in US and India businesses
 
Cipla Ltd. has an average target of 1707.30 from 11 brokers.
More from Cipla Ltd.
Recommended
Market trades higher, Ashok Leyland's promoter pledges shares worth Rs 6,000 crore
Trendlyne Marketwatch | 27 Mar 2025, 12:33PM
India's EV race is heating up | Screener: Auto stocks with rising momentum and strong Forecaster numbers
The Baseline | 27 Mar 2025, 12:31AM
Indian market boosts Cipla in Q4 despite inventory write-off, new product launches will be key
| 20 May 2022